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Mental healthInternet interventions have great potential for alleviating emotional distress, promoting mental health, and
enhancing well-being. Numerous clinical trials have demonstrated their efﬁcacy for a number of psychiatric
conditions, and interventions delivered via the Internet will likely become a common alternative to face-to-
face treatment. Meanwhile, research has paid little attention to the negative effects associated with treatment,
warranting further investigation of the possibility that some patients might deteriorate or encounter adverse
events despite receiving best available care. Evidence from research of face-to-face treatment suggests that
negative effects afﬂict 5–10% of all patients undergoing treatment in terms of deterioration. However, there is
currently a lack of consensus on how to deﬁne and measure negative effects in psychotherapy research in
general, leaving researchers without practical guidelines for monitoring and reporting negative effects in clinical
trials. The current paper therefore seeks to provide recommendations that could promote the study of negative
effects in Internet interventions with the aim of increasing the knowledge of its occurrence and characteristics.
Ten leading experts in the ﬁeld of Internet interventions were invited to participate and share their perspective
on how to explore negative effects, using the Delphi technique to facilitate a dialog and reach an agreement. The
authors discuss the importance of conducting research on negative effects in order to further the understanding
of its incidence and different features. Suggestions on how to classify and measure negative effects in Internet
interventions are proposed, involving methods from both quantitative and qualitative research. Potential mech-
anisms underlying negative effects are also discussed, differentiating common factors shared with face-to-face
treatments from those unique to treatments delivered via the Internet. The authors conclude that negative effects
are to be expected and need to be acknowledged to a greater extent, advising researchers to systematically probe
for negative effects whenever conducting clinical trials involving Internet interventions, as well as to share their
ﬁndings in scientiﬁc journals.
© 2014 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
During the last two decades research has provided increasing
evidence for the use of Internet interventions (Andersson et al., 2013).
Numerous clinical trials have demonstrated the efﬁcacy of treatmentsogy, Department of Psychology,
91, Sweden. Tel.: +46 8 16 38
(A. Rozental).
. Open access under CC BY-NC-ND licedelivered via the Internet for a wide range of psychiatric conditions,
e.g., depression (Wagner et al., 2014), social phobia (Andrews et al.,
2011), panic disorder (Carlbring et al., 2006), generalized anxiety
disorder (Titov et al., 2009), insomnia (van Straten et al., 2013), tinnitus
(Nyenhuis et al., 2013), pathological gambling (Carlbring and
Andersson, 2006), comorbid anxiety disorders (Johnston et al., 2013),
irritable bowel syndrome (Ljótsson et al., 2011), among others. Until re-
cently, Internet interventions have mainly involved the use of cognitive
behavior therapy. However, current research also indicates that psycho-
dynamic psychotherapy can be delivered as guided self-help withnse.
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iety disorders (Andersson et al., 2012a; Johansson et al., 2013a), as well
as guided physical activity (Ström et al., 2013), and problem-solving
therapy (Warmerdam et al., 2008). Internet interventions are assumed
to have several advantages over face-to-face treatment, e.g., higher cost-
effectiveness, increased access to evidence-based treatments, and great-
er opportunity to reach patients on remote locations (Carlbring and
Andersson, 2006). Hence, it is reasonable to assume that Internet inter-
ventions will become a common alternative to face-to-face treatments
in order to meet an increasing demand of mental health services
(Johansson et al., 2013b; Kohn et al., 2004).
Because research on Internet interventions has primarily focused
on examining its effectiveness little is known about the occurrence or
characteristics of negative effects (Boettcher et al., 2014). However,
this is far from unique in its ﬁeld and reﬂects a major shortcoming of
psychotherapy research in general (Nutt and Sharpe, 2008). Investiga-
tions on negative effects have primarily dealt with so called fringe
psychotherapies or potentially harmful therapies, e.g., rebirthing,
scared straight interventions, critical incidence stress debrieﬁng, and
recovered-memory techniques, whilst paying less attention to the
potential negative effects of evidence-based treatments (Berk and
Parker, 2009; Beyerstein, 2001). In recent years, the importance of
exploring negative effects of established treatments has also been pro-
posed in order to avoid the possibility of some patients getting worse
despite receiving best available care (Barlow, 2010). Similarly, Foulkes
(Foulkes, 2010) pointed out that any treatment with the potential of
alleviating distress also carries with it the risk of evoking negative
effects. In other words, therapists should be aware of the probability
of inadvertently inducing negative effects during the course of treat-
ment (Castonguay et al., 2010).
To what extent negative effects occur in psychotherapy is a topic of
great debate (Boisvert, 2010). Bergin (Bergin, 1966) is often acknowl-
edged as the ﬁrst person to describe the possibility of a treatment
producing negative effects, although earlier examples are mentioned
in the literature, e.g., Mohr (Mohr, 1995) presents a complete review.
Bergin (Bergin, 1966) examined several psychotherapy outcome
studies and found that some patients consistently seem to deteriorate
during treatment. Lambert (Lambert, 2007) has suggested that between
5 and 10% of all patients undergoing psychotherapy deteriorate, a num-
ber that also appears in clinical trials at different outpatient care settings
(Hannan et al., 2005; Hatﬁeld et al., 2010; Heins et al., 2010; Lambert
et al., 2002). However, determining whether the negative effects are a
consequence of treatment requires a comparison group to control for
the natural course of the target problem (Dimidjian and Hollon, 2010).
Also, deterioration may not be the only negative effect associated with
treatment (Boisvert and Faust, 2002). Hadley and Strupp (1976) con-
ducted a survey among researchers and therapists on the prevalence
and deﬁnition of negative effects, resulting in a summary of possible
detrimental effects of psychotherapy ranging from low self-esteem to
becoming dependent on the therapist. They proposed a tripartite
model in which negative effects are assessed from the perspective of
the patient, the therapist, and society (Strupp and Hadley, 1977;
Strupp et al., 1977). Lilienfeld (2007) made a similar distinction, stating
that any intervention might be experienced as negative by the patient,
e.g., assertiveness training or exposure in vivo, even though it is
believed by the therapist to be beneﬁcial in the long run. Likewise, the
outcome of psychotherapy in terms of symptom reduction, increased
well-being, and greater independence does not necessarily represent a
positive result for a partner or relative, who may have been enjoying
secondary beneﬁts from the patient's disorder (Crown, 1983; Kottler
and Carlson, 2003; Stuart, 1970). Furthermore, Dimidjian and Hollon
(2010) suggested that treatment nonresponse should also be considered
negative, as it could have prevented the patient from receiving more
adequate care, or experiencing spontaneous remission, prolonging or
even increasing the distress. In sum, determining what constitute
negative effects of treatment depends on both the perspective fromwhich the treatment is evaluated (e.g., patient, therapist, signiﬁcant
other, or society) and what is regarded as a favorable outcome (Foa
and Emmelkamp, 1983; Mays and Franks, 1980).
In comparison to psychotherapy research, monitoring negative ef-
fects is requiredwhen evaluating the beneﬁts and risks of pharmacolog-
ical medication (Wysowski and Swartz, 2005). In order to introduce a
new drug, as well as to surveil possible adverse events of an existing
drug, investigating negative effects is essential and regulated by the
pharmaceutical industry, government agencies, as well as international
committees, e.g., World Health Organization (Curtin and Schulz, 2011).
Assessment is often based on beneﬁt–risk ratios, quantifying the
numbers of favorable outcomes achieved for each additional unfavor-
able outcome (Willan et al., 1997). However, the usefulness of this
framework is limited to clinical trials using a single outcome measure
and can only distinguish one type of adverse event at a time (Willan
et al., 1997). Methods for exploring other possible negative effects
have therefore been suggested (Curtin and Schulz, 2011). Kalachnik
(1999) provides a review of the most common monitoring procedures
of negative effects of pharmacological medication: measurements can
be administered on an organizational level, e.g., retrospective data col-
lected from patient journals or the use of laboratory methods, rating
scales and checklists for speciﬁc negative effects or negative effects in
general, and applied individual methods adapted from behavioral
psychology, e.g., examining the frequency, intensity, and duration of
a target behavior. Negative effects can also be classiﬁed as either pre-
dictable reactions or unexpected or idiosyncratic reactions (Edwards
and Biriell, 1994). Kalachnik (1999) points out that no method will
detect all negative effects and that it is advised to use a combination
of measures when conducting clinical trials or examining negative ef-
fects in clinical practice. Similar to psychotherapy research, the medical
literature is not uniform in terms of its terminology, resulting in the use
of different deﬁnitions to describe the same phenomenon (Edwards and
Biriell, 1994). The recommendation is therefore to report all negative
effects of a drug even though it might not be related to the medication
in use (Goldmann et al., 1995). This is deemed important as it could
facilitate hypothesis generation, further investigation, and possibly the
need for precautionary measures (Kalachnik, 1999).
Recently, the need for expanded monitoring of negative effects in
clinical trials of psychotherapy has been discussed, resulting in different
suggestions on how to deﬁne and measure negative effects (Peterson
et al., 2013). Linden (2013) presented a comprehensive checklist divid-
ing negative effects into different categories. This involves events and
reactions unrelated to treatment, nonresponse, deterioration of illness,
therapeutic risks and contraindications, and negative effects attribut-
able to the treatment per se. Negative effects are however consistently
deﬁned as side effects, a concept primarily used in research of pharma-
cologicalmedication (Kalachnik, 1999), but has previously been advised
byMays and Franks (1985) not to be used in psychotherapy research as
it does not reveal whether the side effects are positive or negative. Fur-
thermore, malpractice reactions are also included, although some argue
that they should be distinct from negative effects of evidence-based
treatments (Berk and Parker, 2009). On the one hand, Linden's (2013)
checklist has a number of advantages in terms of detecting negative
effects of treatment as it incorporates the perspectives of both the
patient and the therapist, as well as deterioration on validated outcome
measures. Parker et al. (2013) on the other hand, have proposed a ques-
tionnaire intended to survey the experiences of patients undergoing or
having completed psychotherapy. In their research, negative effects
were evaluated in relation to premature treatment termination, and
then quantiﬁed and categorized according to recurrent themes. Results
indicated that ineffective treatment, external factors (e.g., lack ofmoney
or time, and currentwork situation), and a dislike of the therapist or the
therapeutic orientation were common reasons to terminate treatment
prematurely. In particular, negative therapeutic alliance was deemed
an important mechanism related to negative effects, but also non-
speciﬁc therapeutic factors, e.g., relocation of therapist and interfering
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of information, determining negative effects solely on the basis of self-
reports does not reveal whether it affects treatment outcome, making
it difﬁcult to conclude whether the experiences of the patient have a
long term negative effect (Dimidjian and Hollon, 2010).
Despite the many complexities surrounding the investigation of
negative effects, further research is needed in order to prevent patients
from encountering adversities and experiencing deterioration caused
by treatment (Barlow, 2010). However, because no consensus currently
exists regarding thedeﬁnition and procedures ofmeasuringnegative ef-
fects the ﬁeld lacks a common ground to guide its research (Peterson
et al., 2013). Dimidjian and Hollon (2010) recently suggested that
methods from both qualitative and quantitative research should be
used, ranging from descriptive case studies to randomized controlled
trials. Self-reports from individual patients could for instance provide
a rich narrative inwhich possible relationships between an intervention
and negative effects are explored. Contrasting deterioration rates
between randomized conditions in a clinical trial could on the other
hand reveal if negative effects are more common in the presence or
absence of treatment, as well as uncovering possible patient character-
istics associated with negative effects (Dimidjian and Hollon, 2010).
Even though these guidelines were initially intended for face-to-face
treatment, they can also be modiﬁed and used in research of Internet
interventions. Since most treatments delivered via the Internet are
derived from face-to-face treatments there is a reason to believe that
they share some commonalities, both in terms of positive and negative
effects. It is also plausible that there are negative effects unique for Inter-
net interventions. The treatment could for instance be experienced as
negative by some patients when unaccompanied by a therapist, partic-
ularly in the event of relapse. Similarly, technical issues and difﬁculties
understanding the treatment rationale might interfere with progress
and result in dropout. Understanding the occurrence and characteristics
of negative effects in Internet interventions is thus important, and could
lend valuable information on how to prevent negative effects from
occurring. In addition, investigating both positive and negative effects
of Internet interventions is important in order to fulﬁll the ethical and
legal considerations of conducting treatments via the Internet (Dever
Fitzgerald et al., 2010). Although the suggestions of Peterson et al.
(2013), Linden (2013), and Parker et al. (2013) are useful, it is essential
to extend the discussion of negative effects to the ﬁeld of Internet inter-
ventions. The current paper therefore seeks to explore ways of deﬁning
and reporting negative effects in Internet interventions in order to form
a consensus and provide researchers with recommendations that could
be used in clinical trials.
2. Material and methods
In order to form a consensus statement ten leading experts in Inter-
net interventions were invited by the ﬁrst author to share their
thoughts on the topic of negative effects and endorse the results, all of
whom accepted participation. The experts were selected based on
their extensive experience of conducting clinical trials in different ﬁelds
of Internet interventions, including outpatient clinics and research facil-
ities, and a number of psychiatric conditions. The Delphi technique was
employed to facilitate a dialog between participants and reach an agree-
ment (Danial-Saad et al., 2013; Spinelli, 1983). This techniquewas orig-
inally developed to enhance forecasting and decision making of
interacting groups, i.e., considering multiple sources of information
and improving creativity, while preventing conformity and social inhi-
bition. The process usually involves four key elements: anonymity, iter-
ation, controlled feedback, and a statistical aggregation of group
response (Danial-Saad et al., 2013; Rowe and Wright, 1999). However,
due to the qualitative nature of the current investigation, the use of a
statistical aggregation was not appropriate, and a summary of common
themes was developed instead. First, the participants were asked to
complete an online survey anonymously regarding negative effects inInternet interventions adapted from Hadley and Strupp (1976) (see
Appendix A). Second, the responses were compiled and sent out for re-
view, allowing the participants to comment on each other anonymous-
ly. Third, the result from this procedure was used to draft a consensus
statement, i.e., the current paper, which the participants were request-
ed to examine and modify before it was submitted for publication. This
enabled additional information to be provided throughout the process
of reaching an agreement, and allowed revisions of previous state-
ments. A similar approach was used to establish guidelines for execut-
ing and reporting Internet intervention research, albeit without the
aid of the Delhi technique (Proudfoot et al., 2011). The outcome of the
consensus statement is presented below summarizing the issues in
need of consideration when monitoring and reporting negative effects
in Internet interventions, followed by recommendations that will
guide future research.
3. Results
3.1. The problem of negative effects
Clinical trials investigating negative effects of Internet interventions
is currently scarce, and only recently has the issue been acknowledged
in the research (Boettcher et al., 2014). Prior knowledge regarding its
occurrence and characteristics is therefore lacking, as well as recom-
mendations on monitoring procedures and the process of reporting
the results. Consequently, there is still insufﬁcient evidence to talk
about a problem of negative effects, even though it has been suggested
that a proportion of all patients undergoing face-to-face treatment dete-
riorate (Lambert, 2007). However, the lack of knowledge does not imply
that negative effects are absent in Internet interventions, rather that
more research iswarranted in order to determine its prevalence and im-
plications, as well as to improve the understanding of the mechanisms
underlying negative effects. A greater awareness of the possibility that
negative effects might occur is therefore important, and different
measures for monitoring negative affects should be applied when
conducting clinical trials of Internet interventions.
Recommendation: Researchers need to be mindful of the fact that
some patients could experience adverse events and deteriorate dur-
ing treatment, and systematically probe and report negative effects
when performing clinical trials of Internet interventions. This
would increase the knowledge of negative effects, and hopefully re-
sult in the implementation of precautionary measures. The follow-
ing aspects have been identiﬁed as particularly important when
examining negative effects in Internet interventions and need to
be recognized.
3.1.1. Similarity
Internet interventions share many similarities with face-to-face
treatments in terms of the methods and techniques being used. Most
treatments are for instance adopted from evidence-based treatments
and use the same treatment manuals for different psychiatric condi-
tions. Admitting that negative effects exist and could pose a problem
in face-to-face treatment also assumes its presence in Internet interven-
tions, which conveys the relevance of conducting further investigation
regardless of treatment format. Negative effects should therefore be ex-
pected and considered in research of Internet interventions, and could
presumably further the understanding of negative effects in general.
3.1.2. Differences
Despite a great overlap, the context in which Internet interventions
is performed can also be associated with a unique set of negative effects
for somepatients undergoing treatment. Unguided self-helpmay for in-
stance be related to a greater risk ofmisunderstanding the treatment ra-
tionale. Inadequate delivery of certain interventions may also
contribute to the experience of adverse events, e.g., performing behav-
ioral experiments that are not carefully planned, or exposure in vivo
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ternet interventions lack the same degree of control and possibility to ad-
dress adherence or comprehension of treatment content. Also, the
communication between patient and therapist is often limited, i.e., lack
of feedback, and non-verbal stimuli, which might be a potential source
of misinterpretation and making it more difﬁcult to correct potential
errors. However, Internet interventionsmay also comprise several advan-
tages thatmight be beneﬁcial for somepatients, e.g., increased opportuni-
ty to contact the therapist during treatment, and a high degree of
structure. Although some negative effects might be inherent in Internet
interventions, it is also reasonable to assume that there are aspects that
prevent some of the negative effects that could be associated with face-
to-face treatments, warranting further research on the differences of neg-
ative effects between face-to-face treatment and Internet interventions.
3.1.3. Causality
Recognizing the occurrence of negative effects does not imply a
causal relationship between the interventions in use and the adversities
or deterioration experienced by the patient. Negative effects could for
instance be caused by circumstances unrelated to treatment, e.g., inter-
personal problems, ﬁnancial difﬁculties, or vocational issues, as well as
the natural course of the target problem (Dimidjian and Hollon, 2010).
Understanding the mechanisms underlying negative effects motivates
an investigation of causality, similar to studying the possible links be-
tween the properties of a certain drug and its negative effects in phar-
macological research (Kalachnik, 1999). Thus, it is necessary to
compare treatment conditions in randomized controlled trials in order
to determine the prevalence and characteristics of negative effects, i.e.,
guided versus unguided self-help, and treatment versus no treatment.
Similarly, differentiating negative effects of Internet interventions
from face-to-face treatment could also be informative, highlighting
common factors that are related to negative effects.
3.2. Classifying negative effects
Negative effects are deﬁned differently depending on the scope of
the research and the terminology being used, varying from deteriora-
tion and nonresponse, to the emergence of novel symptoms and social
implications. Consequently, research on negative effects can often be
interpreted in a number of ways, obfuscating the results and the under-
standing of underlying mechanisms (Edwards and Biriell, 1994;
Peterson et al., 2013). Using amore coherent classiﬁcationmay promote
the investigation of negative effects by providing a clear set of deﬁni-
tions that would guide the research forward.
3.2.1. Recommendation
Using a mutual terminology would facilitate monitoring and
reporting of different types of negative effects that occur during treat-
ment. The following deﬁnitions have been adopted from research
of negative effects in face-to-face treatment (Linden, 2013), and re-
searchers are advised to use these as a uniform classiﬁcation for deﬁning
negative effects in Internet interventions.
3.2.1.1. Deterioration. Deterioration is deﬁned as worsening of target
symptoms andmonitored by a validated outcomemeasure or behavior-
almeasure, i.e., an increase of symptom severity, or increased frequency
of intrusive thoughts. In order to distinguish temporary from enduring
deterioration, consecutive measures and follow-up are also recom-
mended, e.g., from pre- to post-treatment, weekly during treatment,
and from post-treatment to follow-up.
3.2.1.2. Adverse events. Adverse events consist of negative events proba-
bly emerging from treatment and perceived as adverse by the patient,
causing deterioration of target symptoms and/or negative experiences
that extends beyond the completion of treatment, e.g., increased anxi-
ety during interoceptive exposure, or being embarrassed by performingassertiveness training. Adverse events could reveal negative effects that
are directly attributable to treatment, providing researchers with infor-
mation on possible mechanisms underlying negative effects.
3.2.1.3. Severe adverse events. Severe adverse events are composed of
negative events that occur during treatment and result in deterioration
of target symptoms and/or adverse reactions requiring some form of
high intensity treatment, e.g., misuse of alcohol or drugs, deliberate
self-harm, and suicidal ideation or attempts. Because of the risks in-
volved, severe adverse events should always be surveiled and reported
regardless if they are deemed related to treatment or not.
3.2.1.4. Novel symptoms. Novel symptoms consist of the emergence of
new psychological symptoms, unrelated to the symptoms targeted in
treatment, whichmay ormay not be associatedwith treatment, e.g., oc-
currence of insomnia during treatment of social anxiety, or decreased
self-esteem during treatment of panic disorder. Similar to adverse
events, novel symptoms could provide valuable information on nega-
tive effects that would otherwise go unnoticed, but differs from adverse
events as novel symptoms should be unrelated to the symptoms
targeted in treatment.
3.2.1.5. Dropout. Dropout concerns the number of patients choosing to
end treatment prematurely. Early termination can be relatedwith dete-
rioration of target symptoms, nonresponse, and/or experiencing
adverse events, presumably related to treatment, e.g., increase in symp-
tom severity, or demoralization. Examining its occurrence in different
treatment conditions as well as compared to face-to-face treatment
could in turn help researchers investigate what factors are associated
with higher dropout. However, if feasible, determining the reason for
dropout is advised as itmay also be related to a decrease in symptom se-
verity, i.e., some patients might experience relief after a short period of
time, perceiving more treatment as redundant.
3.2.1.6. Nonresponse. Nonresponse is characterized by the lack of a pre-
dicted positive effect on target symptoms, possibly attributable to treat-
ment, resulting in status quo, demoralization and discouragement to
seek help elsewhere, i.e., absence of any treatment effect. However, fur-
ther exploration is required in order to distinguish the reason for reason
and characteristics of the nonresponse, i.e., some patients might have
deteriorated without treatment, or external factors might be responsi-
ble for the nonresponse, e.g., bereavement, or other social stressors.
3.2.1.7. Unwanted events. Unwanted events are deﬁned as all events ex-
perienced as negative by the patient during treatment, which may or
may not be related to the interventions being used, and does not neces-
sarily inﬂuence treatment outcome, e.g., issues related to the treatment
content, increased anxiety during exposure in vivo, and frustration
caused by technical issues. Unwanted events do not provide any
etiological assumptions, but could facilitate an understanding of what
negative effects might be associated with treatment.
3.3. Monitoring negative effects
The investigation of negative effects can bepursued inmultipleways
depending on the measures and routines being involved. Assessment
could rely solely on validated outcome measures in order to determine
deterioration, e.g., exacerbationof social anxiety frompre- topost-treat-
ment (Barlow, 2010). However, negative effects unrelated to an in-
crease in symptom severity may also occur, and the experiences of
negative effects might vary from patient to patient, warranting the use
of additional monitoring procedures (Parker et al., 2013; Peterson
et al., 2013). Self-reports, interviews, checklists, and open-ended ques-
tions could therefore be equally important when conducting research
of negative effects in Internet interventions, identifying aspects that
would have been difﬁcult to distinguish with validated outcome
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tics of negative effects between treatment conditions may also reveal
important differences, e.g., greater incidence of negative effects in
wait-list control compared to treatment.
3.3.1. Recommendation
As a minimum, researchers are advised to investigate negative
effects using validated outcomemeasures in order to determine deteri-
oration between pre- and post-treatment, and between different treat-
ment conditions. Researchers are also recommended to report the
number of patients who did not respond to treatment as well as the
number of patients who deteriorated during treatment. Furthermore,
researchers are urged to probe for negative effects via self-report
measures administered at post-treatment, i.e., “did you experience
any negative effects during treatment”. The following monitoring pro-
cedures are put forward to facilitate future research of negative effects
in Internet interventions.
3.3.1.1. Standard outcome measures. The use of validated outcome mea-
sures is considered a standard practice in order to determine the efﬁca-
cy of treatment. Outcome measures are therefore already included in
most clinical trials of Internet interventions, and do not require any ad-
ditional monitoring procedures in terms of investigating deterioration.
Hence, assessment of negative effects should at least be performed by
comparing scores from pre- to post-treatment, as well as from post-
treatment to follow-up, indicating whether an increase in symptom se-
verity is temporary or enduring (Dimidjian and Hollon, 2010). In addi-
tion, researchers are also advised to investigate negative effects on a
consecutive basis, involving measures administered weekly during
treatment or wait-list control. Besides validated outcome measures for
speciﬁc psychiatric conditions, more global assessments of functioning
orwell-being are also possible to use (Lindner et al., 2013) aswell as be-
havioralmeasures where applicable (Haynes et al., 1997). Deterioration
on any outcomemeasure could also be deﬁned according to the criteria
of reliable deterioration deﬁned by Jacobson and Truax (1991). In this
approach, a critical difference between pre- and post-score/post- and
follow-up-score is deﬁned taking into account the reliability of the in-
strument. When possible, researchers could apply standard critical dif-
ferences, for instance as deﬁned for the Beck Depression Inventory
(Seggar et al., 2002).
3.3.1.2. Additional self-report measures. The nature of negative effects
may differ between patients and treatment conditions, warranting the
use of self-report measures (Parker et al., 2013). Probing for adverse
events could for instance reveal social implications or subjective experi-
ences which are difﬁcult to detect using only validated outcome mea-
sures. Self-report measures could consist of open-ended questions at
post-treatment or following wait-list control, but should be adminis-
tered weekly where possible in order to detect negative effects which
might otherwise be forgotten by the patient. It may also involve semi-
structured interviews exploring the unique perspective of the patient,
or standardized checklists addressing some of the most frequently
occurring negative effects of Internet interventions.
3.3.1.3. Clinical interviews. Administering a clinical interview could re-
veal negative effects undetected by self-report measures, but which
are still considered negative in terms of affecting long term outcome
(Dimidjian and Hollon, 2010). For instance, patients undergoing treat-
ment with guided self-help might become dependent on the therapist
in order tomanage their distress. Likewise, misunderstanding the treat-
ment rationalemay lead to difﬁculties employing or adhering to speciﬁc
techniques, resulting in self-accusation and a greater risk of relapse. A
clinical interview could therefore provide valuable information from
the perspective of the therapist, and enable a comparison of negative
effects across different viewpoints. In most research settings clinical
interviews such as the Structured Clinical Interview for the DSM(SCID; First et al., 1997) are often administered at post-treatment in
order to determine the proportion of patients no longer fulﬁlling the
diagnostic criteria for the disorder under treatment. However, these
standard interviews do not cover questions on potential negative ef-
fects. Researchers and clinicians should therefore add open questions
concerning the occurrence of possible negative effects that might be
related to treatment.
3.4. Factors associated with negative effects
The investigation of negative effects is scarce, even more so regard-
ing possible underlying mechanisms that might contribute to its occur-
rence. Different suggestions have been proposed in psychotherapy
research in general, mainly involving sociodemographic variables or co-
morbidity that could predict treatment outcome (Hofmann and Suvak,
2006; Steketee and Shapiro, 1995). However, more in-depth analyses
concerning what factors may be associated with negative effects are
currently lacking, preventing researchers from exploring ways of
enhancing treatment procedures and averting negative effects from
occurring. From a theoretical perspective several factors have been put
forward as plausible explanations of negative effects, e.g., the therapeu-
tic relationship, exaggerated expectations of treatment outcome, and
interventions inherent to speciﬁc therapeutic orientations (Berk and
Parker, 2009; Nutt and Sharpe, 2008). Further research of these and
other relevant factorsmay provide evidence of the predictors andmedi-
ators of negative effects. However, theremight also exist differences be-
tween face-to-face treatment and Internet interventions regarding the
mechanisms contributing to negative effects, as well as between guided
and unguided self-help, warranting an investigation of what factors
seem to bemore prevalent inwhat treatment condition, and to compare
these results with ﬁndings from face-to-face treatment.
3.4.1. Recommendation
Investigating factors associated with the occurrence of negative
effects is essential for developing strategies to reduce the risk for nega-
tive effects. There is currently insufﬁcient knowledge concerning the
underlying mechanisms that might contribute to negative effects, and
whether this differs between Internet interventions and face-to-face
treatment, or treatment conditions. Examining possible predictors and
mediators of negative effects is therefore important, and could lead to
improved treatment procedures that may decrease the number of pa-
tients experiencing adversities or deterioration. The following sugges-
tions highlight some of the factors that are believed to be related with
negative effects in treatment, and could be used to guide future research
of Internet interventions.
3.4.1.1. Disappointment. Nonexistent or insufﬁcient treatment progress
can result in feelings of disappointment, particularly if the patient had
high expectations of symptom relief prior to entering treatment. This
might in turn be perceived as negative, leading to both demoralization
and dropout. Furthermore, disappointment could also involve a set of
beliefs regarding the treatment or the effort needed to change, in turn
disruptingboth compliance and the comprehension of the treatment ra-
tionale (Boisvert and Faust, 2002). However, because disappointment
most likely reﬂects the patient's notion of treatment rather than the
treatment in itself, it is reasonable to assume that disappointment oc-
curs in face-to-face treatment as well as Internet interventions, even
though the reason behind the disappointmentmight differ in character.
3.4.1.2. Deﬁcient treatment. The lack of structure or deﬁcient procedures
surrounding the treatment could be an important factor responsible for
negative effects, resulting in frustration, self-accusation, and an in-
creased risk of dropout (Castonguay et al., 2010). Instead of recognizing
defects inherent to the treatment per se, patients might attribute their
difﬁculties to personal features or shortcomings and terminate treat-
ment prematurely. Because Internet interventions do not contain the
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quality of the content and the framework being used is more essential,
highlighting the signiﬁcance of providing treatments that are simple,
accessible, and coherent.
3.4.1.3. Therapist factors. The therapeutic relationship is a signiﬁcant pre-
dictor of treatment outcome in face-to-face treatment (Del Re et al.,
2012), and is assumed to be true for Internet interventions (Bergman
Nordgren et al., 2013). However, the research is currently inconclusive
and the importance of the therapeutic relationship is somewhat unclear
(Andersson et al., 2012b). On the one hand, guided self-help accompa-
nied by a therapist may facilitate behavior change and help some
patients overcome their distress to a greater extent. On the other
hand, guided self-help might also be associated with misunderstand-
ings and alliance ruptures, contributing to the occurrence of negative
effects, perhaps more so for patients suffering from interpersonal difﬁ-
culties or personality disorders. Negative effects could also be more ev-
ident in those cases where the therapist does not have adequate
training, i.e., an untrained or lay therapist, and be affected by the often
unreliable communication inherent in Internet interventions, resulting
in insufﬁcient feedback from the patient and difﬁculties adapting the
therapeutic style in writing or via telephone or video. In other words,
whether or not the therapeutic relationship is a common source of
negative effects in Internet interventions, and more so in treatments
delivered via the Internet than face-to-face treatment, is still unknown
and warrants further investigation.
3.4.1.4. Therapeutic orientation. For the most part, treatments delivered
via the Internet havemainly involvedmethods and interventions stem-
ming from cognitive behavior therapy (Andersson et al., 2013; Mohr
et al., 2013), even though clinical trials have been performed on other
therapeutic orientations as well, e.g., psychodynamic psychotherapy
(Johansson et al., 2013a, 2013b, 2013c), guided physical activity (Hoek
et al., 2012; Ström et al., 2013), and problem-solving therapy
(Warmerdam et al., 2008). Hence, there is still insufﬁcient knowledge
on whether negative effects differ in terms of their occurrence or char-
acteristics between therapeutic orientations. The same situation is evi-
dent in face-to-face treatment, although some evidence suggest that
there are no signiﬁcant differences (Lambert, 2007). However, from a
theoretical standpoint there might be speciﬁc methods and interven-
tions that cause negative effects to a greater extent in the treatment of
certain psychiatric conditions. Performing behavioral experiments and
exposure in vivo is for instance associated with a temporary increase
in distress, even though the long term outcome might be beneﬁcial for
the patient. This could potentially lead to greater dropout compared to
other therapeutic orientations, particularly in Internet interventions
where the patient may lack proper guidance to execute the necessary
interventions and when feedback from the therapist is not always
possible.
3.4.1.5. Patient characteristics. Different patients may receive different
results of the same treatment, partly related to the inﬂuence of speciﬁc
patient characteristics. Sociodemographic variables, health literacy, and
comorbid disorders are for instance regarded as predictors of treatment
outcome, both in treatments delivered via the Internet and face-to-face
treatments (Andersson et al., 2008; Jorm, 2012; Nordgreen et al., 2012;
Spek et al., 2008). Whether these are associated with negative effects is
however unclear, but could reveal important patient characteristics
contributing to the occurrence of adversities and deterioration. Some
patients may prefer conventional treatment in front of guided self-
help, partly explained by prior experience of using the Internet. Like-
wise, some patients might beneﬁt more from a highly structured treat-
ment without any assistance. Speciﬁc patients' characteristics may
therefore facilitate or interfere with treatment, revealing what patients
beneﬁt the most from the interventions being used.4. Conclusion
Internet interventions are becoming increasingly available and offer
a great opportunity to alleviate emotional distress, promote mental
health and enhance well-being (Emmelkamp et al., 2014). As an alter-
native to face-to-face treatment Internet interventions could provide
more patientswith treatments that are effective for awide range of psy-
chiatric conditions (Andersson et al., 2013; Carlbring and Andersson,
2006). However, despite rapid progress little is known about the possi-
bility that some patients might deteriorate or encounter adverse events
during treatment (Boettcher et al., 2014). Evidence from face-to-face
treatments suggests that between 5 and 10% of all patients experience
negative effects in terms of deterioration alone (Hannan et al., 2005;
Hatﬁeld et al., 2010; Lambert, 2007; Lambert et al., 2002). To what ex-
tent other types of negative effects exist is still unclear and a topic of
great debate (Boisvert, 2010), even though it has been proposed that a
number of adverse events occur and should be recognized during treat-
ment, e.g., lower self-esteem, self-accusation, and becoming dependent
on the therapist (Crown, 1983; Dimidjian and Hollon, 2010; Lilienfeld,
2007; Strupp and Hadley, 1977). It is also unknown what underlying
mechanisms are associated with negative effects, and whether those
differ between Internet interventions and face-to-face treatment.
Because both share much in common in regard to the methods and
techniques being used, it is highly likely that negative effects also afﬂict
patients undergoing treatments delivered via the Internet. To compre-
hend to what degree negative effects exist in Internet interventions
it is therefore important to conduct research that investigates its occur-
rence and characteristics. Similar to the requirements of evaluating the
beneﬁts and risks of pharmacological medication (Curtin and Schulz,
2011; Kalachnik, 1999; Wysowski and Swartz, 2005), research
concerning treatments delivered via the Internet should monitor and
report negative effects in order to live up to ethical and legal consider-
ations (Dever Fitzgerald et al., 2010). The current paper invited leading
experts in the ﬁeld of Internet interventions and put forward a number
of recommendations that are intended to provide researchers with
guidelines when performing clinical trials. First, negative effects are to
be acknowledged and examined across treatment conditions as well
as between Internet interventions and face-to-face treatment in order
to further the understanding of its incidence and facilitate an analysis
of causality. Second, a uniform classiﬁcation of negative effects is pro-
posed to ease monitoring procedures and the process of reporting the
results in scientiﬁc journals. Third, measuring negative effects should
use methods from both quantitative and qualitative research that will
be able to detect deterioration as well as the subjective experiences of
the patient. Forth, investigating factors associated with negative effects
are endorsed as it could delineate underlying mechanisms contributing
to its incidence. The recommendations presented in the current
paper are in line with the suggestions proposed by Peterson et al.
(2013), Linden (2013), and Parker et al. (2013), but extend the dis-
cussion of negative effects to the ﬁeld of Internet interventions, pro-
viding practical steps that can guide the research forward and lend
valuable information on how to prevent negative effects from occur-
ring in the future.5. Competing interests
The authors have declared that no competing interests exist.Acknowledgement
This study wasmade possible by a generous grant from the Swedish
Research Council for Health, Working Life and Welfare (FORTE 2013-
1107). The funder had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
18 A. Rozental et al. / Internet Interventions 1 (2014) 12–19Appendix A
1. Is there a problem of negative effects, i.e., can we legitimately speak
of a patient getting worse or experiencing adverse events as a result
of Internet interventions or related treatments, e.g. smartphone
applications?
2. If so,whatwould constitute a negative effect in Internet interventions?
3. By what criteria would one judge a patient as having experienced
negative effects as a result of Internet interventions?
4. While any therapy outcome is obviously a function of many factors,
which factors would you associate with, or consider responsible for,
a negative effect?
5. In your opinion, is there a difference between face-to-face psycho-
therapy and Internet interventions in terms of occurrence and nature
of negative effects?
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